Shoulder Innovations introduced humeral planning capabilities for its ProVoyance Shoulder Software Planning platform. This new feature, which received clearance from FDA, will further support shoulder surgeons by allowing precise planning of all available InSet humeral stems, including the newly released InSet 95 Stem.
The ProVoyance Shoulder platform integrates Artificial Intelligence (AI) and Machine Learning (ML) technologies and converts CT images into accurate 3D reconstructions of the shoulder anatomy.
The addition of humeral planning further enhances this system, providing surgeons with a powerful software tool to tailor surgical strategies to individual patient anatomy, with the goal of improving outcomes.
Rob Ball, CEO of Shoulder Innovations, said, “ProVoyance was the first musculoskeletal application in its class to navigate the rigorous FDA approval process under the QIH classification code, designated for artificial intelligence-enabled software applications. This recognition underscores the platform’s advanced AI/ML capabilities, setting a new standard in surgical planning technology.”
Shoulder Innovations introduced humeral planning capabilities for its ProVoyance Shoulder Software Planning platform. This new feature, which received clearance from FDA, will further support shoulder surgeons by allowing precise planning of all available InSet humeral stems, including the newly released InSet 95 Stem.
The ProVoyance...
Shoulder Innovations introduced humeral planning capabilities for its ProVoyance Shoulder Software Planning platform. This new feature, which received clearance from FDA, will further support shoulder surgeons by allowing precise planning of all available InSet humeral stems, including the newly released InSet 95 Stem.
The ProVoyance Shoulder platform integrates Artificial Intelligence (AI) and Machine Learning (ML) technologies and converts CT images into accurate 3D reconstructions of the shoulder anatomy.
The addition of humeral planning further enhances this system, providing surgeons with a powerful software tool to tailor surgical strategies to individual patient anatomy, with the goal of improving outcomes.
Rob Ball, CEO of Shoulder Innovations, said, “ProVoyance was the first musculoskeletal application in its class to navigate the rigorous FDA approval process under the QIH classification code, designated for artificial intelligence-enabled software applications. This recognition underscores the platform’s advanced AI/ML capabilities, setting a new standard in surgical planning technology.”
Copy to clipboard 
